Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from ImmiR: A database of microRNAs associated with immune checkpoints and infiltrates. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1158/2159-8290.cd-15-1545
10.1158/2159-8290.cd-15-1545 · External reference
Efficacy of immune checkpoint inhibitor monotherapy in elderly patients with non-small-cell lung cancer
10.1016/j.resinv.2023.06.005 · 2023 · External reference
Influence of tumor immune infiltration on immune checkpoint inhibitor therapeutic efficacy: a computational retrospective study
2021 · External reference
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer
10.1073/pnas.1811067116 · 2019 · External reference
Barriers to immune cell infiltration in tumors
10.1136/jitc-2022-006401 · 2023 · External reference
10.1158/0008-5472.can-11-3218
10.1158/0008-5472.can-11-3218 · External reference
10.1016/j.cell.2012.02.005
10.1016/j.cell.2012.02.005 · External reference
Key questions about the checkpoint blockade-are microRNAs an answer?
10.20892/j.issn.2095-3941.2018.0006 · 2018 · External reference
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
10.1073/pnas.1209414109 · 2012 · External reference
10.1016/j.molcel.2010.06.010
10.1016/j.molcel.2010.06.010 · External reference
10.1136/jitc-2024-009774
10.1136/jitc-2024-009774 · External reference
Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment
10.1111/febs.15000 · 2019 · External reference
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
10.1186/s12935-024-03293-6 · 2024 · External reference
ICBcomb: a comprehensive expression database for immune checkpoint blockade combination therapy
10.1093/bib/bbad457 · 2023 · External reference
10.1158/2326-6066.cir-22-0249
10.1158/2326-6066.cir-22-0249 · External reference
ICI efficacy information portal: a knowledgebase for responder prediction to immune checkpoint inhibitors
10.1093/narcan/zcad012 · 2023 · External reference
10.1093/bioinformatics/btz210
10.1093/bioinformatics/btz210 · External reference
10.1136/jitc-2020-001247
10.1136/jitc-2020-001247 · External reference
YM500v3: a database for small RNA sequencing in human cancer research
10.1093/nar/gkw1084 · 2017 · External reference
10.1093/nar/gkae1072
10.1093/nar/gkae1072 · External reference
10.1038/nmeth.3337
10.1038/nmeth.3337 · External reference
10.1186/s13059-017-1349-1
10.1186/s13059-017-1349-1 · External reference
10.1093/nar/gkaa407
10.1093/nar/gkaa407 · External reference
10.1186/s13059-016-1070-5
10.1186/s13059-016-1070-5 · External reference
10.7554/elife.26476
10.7554/elife.26476 · External reference
10.1186/s13073-019-0638-6
10.1186/s13073-019-0638-6 · External reference
10.1038/s41591-018-0136-1
10.1038/s41591-018-0136-1 · External reference
ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy
2020 · External reference
10.1038/ncomms3612
10.1038/ncomms3612 · External reference
10.3390/cancers15041264
10.3390/cancers15041264 · External reference
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
2016 · External reference
Aerosolized miR-138-5p and miR-200c targets PD-L1 for lung cancer prevention
10.3389/fimmu.2023.1166951 · 2023 · External reference
MicroRNA-326 attenuates immune escape and prevents metastasis in lung adenocarcinoma by targeting PD-L1 and B7-H3
10.1038/s41420-021-00527-8 · 2021 · External reference
The miR-125a-3p inhibits TIM-3 expression in AML cell line HL-60 in vitro
10.1007/s12288-016-0733-4 · 2017 · External reference
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors
10.1158/0008-5472.can-08-4517 · 2009 · External reference
10.1136/jitc-2024-010363
10.1136/jitc-2024-010363 · External reference
miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate
10.1038/s41467-019-09882-8 · 2019 · External reference
Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function
10.1172/jci157248 · 2022 · External reference
10.3892/or.2018.6439
10.3892/or.2018.6439 · External reference
10.1038/s41418-020-00618-6
10.1038/s41418-020-00618-6 · External reference
miR-128 regulates tumor cell CD47 expression and promotes anti-tumor immunity in pancreatic cancer
10.3389/fimmu.2020.00890 · 2020 · External reference
miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint
10.1038/ncomms11406 · 2016 · External reference
miR‑155‑5p regulates macrophage M1 polarization and apoptosis in the synovial fluid of patients with knee osteoarthritis
10.3892/etm.2020.9500 · 2020 · External reference
Exosomal miR-155-5p drives widespread macrophage M1 polarization in hypervirulent Klebsiella pneumoniae-induced acute lung injury via the MSK1/p38-MAPK axis
10.1186/s11658-023-00505-1 · 2023 · External reference
10.1016/j.csbj.2021.12.020 · Admitted local publication
Inhibition of PD-L1 and tumor growth in triple-negative breast cancer using a magnetic nanovector with microRNA34a
10.1186/s12645-023-00171-0 · 2023 · External reference
10.1038/s41375-018-0178-x
10.1038/s41375-018-0178-x · External reference
10.1093/jnci/djv303
10.1093/jnci/djv303 · External reference
10.1038/nrd4140
10.1038/nrd4140 · External reference
